RESEARCH MONOGRAPH · KDC-MN-396

Citrulline Malate

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 3 min read

Our opinion on this compound

76/100

Better arginine delivery than arginine itself; the malate half is mostly marketing

Citrulline malate is the supplement-industry darling that's actually mechanistically interesting in one specific way. Citrulline bypasses hepatic first-pass metabolism that destroys oral arginine, gets converted to arginine in the kidney, and elevates plasma arginine more reliably and durably than equivalent doses of oral L-arginine itself. The Schwedhelm pharmacokinetic work made this clear: oral citrulline is the better way to deliver arginine, full stop.

The malate half is a different story. Malate is a Krebs cycle intermediate and supplementing it has a defensible rationale on paper, but the actual evidence for the malate component contributing to the ergogenic effects of citrulline malate is thin. The Bendahan studies were small and the malate-versus-citrulline comparison work hasnt been done cleanly. So treat malate as a counter-ion that probably doesn't hurt and might help marginally, not as an active ingredient.

The ergogenic literature is mixed but tilts positive. The Perez-Guisado and Wax work showed reductions in muscular fatigue and improvements in resistance-training volume at 8 g/dose. Glenn's research on the cardiovascular and endothelial effects is also reasonable. The effect sizes are smaller than creatine or beta-alanine, but the mechanism (nitric oxide synthase substrate availability) is at least different from those compounds so it can stack mechanistically.

What we like is the kidney conversion biology, which is elegant and underappreciated. Arginine is largely destroyed in first-pass by arginase, citrulline isn't, so you get net-arginine elevation that lasts hours rather than the spike-and-clear pattern of oral arginine.

What we don't like is the marketing portrayal as a 'nitric oxide booster' divorced from any actual NO measurement. Most consumer products are dosed below the 6 to 8 g range that the trial literature uses, and the placebo-controlled effect at lower doses is weak.

Sourcing is straightforward, both L-citrulline and citrulline malate (typically 1:1 or 2:1 ratio) are widely available at high purity. HPLC analysis is routine. Stability is excellent. The malate ratio should be specified on the COA because it changes the elemental composition meaningfully.

Evidence: 70
Mechanism: 80
Reliability: 68
Safety: 90
Sourcing: 88
Value: 80
Signal: 65
Staying power: 70

Plain-language summary Intrigue 55 / 100

Citrulline malate combines L-citrulline (an amino acid your kidneys convert into L-arginine) with malic acid (a TCA cycle intermediate). The trick is that citrulline supplementation actually raises blood arginine more effectively than arginine itself, because it bypasses the intestinal arginase enzyme that destroys most oral arginine before it reaches circulation. Higher arginine fuels nitric oxide synthesis (vasodilation, the famous pre-workout pump) and supports urea cycle ammonia clearance. The malate component helps keep TCA-driven ATP production running. Standard pre-workout dosing is 6 to 10 g taken 60 to 90 minutes before exercise, with reasonable evidence for increased resistance training volume and reduced post-workout soreness. Among the more credible pre-workout ingredients. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Amino acid + organic acid (NO precursor / TCA cycle support)

L-citrulline complexed with malic acid; a nitric oxide precursor (via arginine) and TCA cycle substrate used in pre-workout supplements.

Abstract

Citrulline malate (L-citrulline DL-malate, CAS 70796-17-7; complex of L-citrulline (CAS 372-75-8, C6H13N3O3, MW 175.19) and malic acid (CAS 6915-15-7, C4H6O5, MW 134.09); commercial 2:1 or 1:1 ratios) is a complex of the amino acid L-citrulline with malic acid. L-citrulline is converted in the kidneys to L-arginine, the substrate for nitric oxide synthase; circulating arginine produced from citrulline supplementation is paradoxically more effective than direct arginine supplementation owing to the bypass of intestinal arginase. The malic acid portion is a TCA cycle intermediate supporting aerobic ATP production. Combined, the compound improves exercise performance through vasodilation (nitric oxide-mediated), reduced ammonia accumulation (urea cycle support), and ATP production. Plasma half-life of citrulline is approximately 1 hour. Used widely in pre-workout supplements (8 to 10 g doses, 60 to 90 minutes pre-exercise) with documented effects on resistance training volume and reduced post-exercise soreness.

Mechanism of action

L-citrulline converted to L-arginine in kidney; supports nitric oxide synthesis (vasodilation) and urea cycle ammonia clearance. Malate supports TCA cycle ATP production.

Reported research dose ranges

Reported research dose ranges vary across the published literature.

References

Perez-Guisado J, Jakeman PM. Citrulline malate enhances athletic anaerobic performance and relieves muscle soreness. J Strength Cond Res 2010.
Bailey SJ, et al. L-Citrulline supplementation improves O2 uptake kinetics and high-intensity exercise performance in humans. J Appl Physiol 2015.
Glenn JM, et al. Acute citrulline malate supplementation improves upper-body resistance exercise performance. Eur J Sport Sci 2017.

Read the full monograph

Available as a research-use-only PDF download.

KDC-MN-396

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Citrulline Malate

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs